PL130497B1 - Process for preparing novel derivatives of 3-aryl-5-isothiazole - Google Patents
Process for preparing novel derivatives of 3-aryl-5-isothiazole Download PDFInfo
- Publication number
- PL130497B1 PL130497B1 PL1981233103A PL23310381A PL130497B1 PL 130497 B1 PL130497 B1 PL 130497B1 PL 1981233103 A PL1981233103 A PL 1981233103A PL 23310381 A PL23310381 A PL 23310381A PL 130497 B1 PL130497 B1 PL 130497B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- acid
- group
- compounds
- uric acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/189,435 US4346094A (en) | 1980-09-22 | 1980-09-22 | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL233103A1 PL233103A1 (enExample) | 1982-12-20 |
| PL130497B1 true PL130497B1 (en) | 1984-08-31 |
Family
ID=22697314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1981233103A PL130497B1 (en) | 1980-09-22 | 1981-09-19 | Process for preparing novel derivatives of 3-aryl-5-isothiazole |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4346094A (enExample) |
| EP (1) | EP0048615B1 (enExample) |
| JP (1) | JPS5785379A (enExample) |
| KR (1) | KR830007597A (enExample) |
| AR (1) | AR229103A1 (enExample) |
| AT (1) | ATE7657T1 (enExample) |
| AU (1) | AU7551681A (enExample) |
| CS (1) | CS228536B2 (enExample) |
| DD (1) | DD201790A5 (enExample) |
| DE (1) | DE3163900D1 (enExample) |
| DK (1) | DK417981A (enExample) |
| ES (1) | ES8301225A1 (enExample) |
| FI (1) | FI812940L (enExample) |
| GB (1) | GB2084573B (enExample) |
| GR (1) | GR75046B (enExample) |
| IL (1) | IL63890A0 (enExample) |
| NO (1) | NO813208L (enExample) |
| PL (1) | PL130497B1 (enExample) |
| PT (1) | PT73711B (enExample) |
| RO (1) | RO82216A (enExample) |
| YU (1) | YU227181A (enExample) |
| ZA (1) | ZA816549B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4428956A (en) | 1980-12-29 | 1984-01-31 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4431652A (en) * | 1980-12-29 | 1984-02-14 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4539328A (en) * | 1983-03-25 | 1985-09-03 | Fmc Corporation | Nematicidal isothiazole derivatives |
| US4620865A (en) * | 1983-11-07 | 1986-11-04 | Eli Lilly And Company | Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides |
| IE59813B1 (en) * | 1986-05-09 | 1994-04-06 | Warner Lambert Co | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
| ZW21687A1 (en) * | 1986-12-12 | 1988-07-20 | Hoffmann La Roche | Triazine derivatives |
| JP2725886B2 (ja) * | 1990-11-30 | 1998-03-11 | 帝人株式会社 | ２―アリールチアゾール誘導体及びその医薬組成物 |
| US5294630A (en) * | 1992-07-07 | 1994-03-15 | Eli Lilly And Company | Treatment of inflammatory bowel disease |
| US5436258A (en) * | 1992-09-09 | 1995-07-25 | Eli Lilly And Company | Prevention of bone resorption |
| MY117352A (en) * | 1995-10-31 | 2004-06-30 | Ciba Sc Holding Ag | Oximesulfonic acid esters and the use thereof as latent sulfonic acids. |
| ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| EP1044002A4 (en) | 1997-11-07 | 2003-05-02 | Univ Johns Hopkins | METHODS FOR THE TREATMENT OF HEART CONTRACTILITY |
| TW575792B (en) * | 1998-08-19 | 2004-02-11 | Ciba Sc Holding Ag | New unsaturated oxime derivatives and the use thereof as latent acids |
| SG78412A1 (en) | 1999-03-31 | 2001-02-20 | Ciba Sc Holding Ag | Oxime derivatives and the use thereof as latent acids |
| CA2474532A1 (en) | 2002-02-06 | 2003-08-14 | Peter Murer | Sulfonate derivatives and the use therof as latent acids |
| EP1783116B1 (en) * | 2004-08-27 | 2009-08-26 | Astellas Pharma Inc. | 2-phenylpyridine derivative |
| JPWO2006022375A1 (ja) * | 2004-08-27 | 2008-05-08 | アステラス製薬株式会社 | ２−フェニルチオフェン誘導体 |
| WO2007043457A1 (ja) | 2005-10-07 | 2007-04-19 | Astellas Pharma Inc. | トリアリールカルボン酸誘導体 |
| MX2008010646A (es) | 2006-02-24 | 2008-10-14 | Astellas Pharma Inc | Agente para tratar o prevenir ulcera digestiva. |
| GB2450975B (en) | 2007-07-12 | 2010-02-24 | Ciba Holding Inc | Yellow radiation curing inks |
| EP2668953A1 (en) * | 2008-05-22 | 2013-12-04 | Bristol-Myers Squibb Company | Pharmaceutical compositions comprising an SGLT2 inhibitor with a supply of carbohydrate and/or an inhibitor of uric acid synthesis |
| PL2404908T3 (pl) | 2009-02-27 | 2014-12-31 | Teijin Ltd | Sposób wytwarzania podstawionej fenylem pochodnej heterocyklicznej przez sprzężenie z użyciem katalizatora metalu przejściowego |
| JP2012522084A (ja) | 2009-03-30 | 2012-09-20 | ビーエーエスエフ ソシエタス・ヨーロピア | Ｕｖ線量インジケータフィルム |
| RU2563459C2 (ru) | 2010-08-27 | 2015-09-20 | Тейдзин Фарма Лимитед | Способ получения фенилзамещенного гетероциклического производного посредством способа сочетания с использованием соединения палладия |
| US9310677B2 (en) | 2011-01-28 | 2016-04-12 | Basf | Polymerizable composition comprising an oxime sulfonate as thermal curing agent |
| RU2632884C2 (ru) * | 2013-03-29 | 2017-10-11 | Тейдзин Фарма Лимитед | Производное пиразола |
| WO2016030790A1 (en) | 2014-08-29 | 2016-03-03 | Basf Se | Oxime sulfonate derivatives |
| MX375374B (es) | 2015-04-29 | 2025-03-06 | Bsn Medical Gmbh | Dispositivo de baño médico. |
| CA2984044A1 (en) | 2015-04-29 | 2016-11-03 | Bsn Medical Gmbh | Steady-state no production via ph control |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1178604A (en) * | 1966-03-21 | 1970-01-21 | American Cyanamid Co | Novel Pyridinium Salts and Methods for Preparing Same |
| US3464999A (en) * | 1967-07-27 | 1969-09-02 | R & L Molecular Research Ltd | Thiadiazolylisothiazoles |
| GB1180268A (en) * | 1967-09-26 | 1970-02-04 | Ici Ltd | Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives |
| GB1192701A (en) * | 1968-03-22 | 1970-05-20 | Ici Ltd | Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same |
| US3681498A (en) * | 1970-10-19 | 1972-08-01 | American Cyanamid Co | Isothiazolyl pyridinium salts as hypoglycemic agents |
-
1980
- 1980-09-22 US US06/189,435 patent/US4346094A/en not_active Expired - Lifetime
-
1981
- 1981-09-19 PL PL1981233103A patent/PL130497B1/pl unknown
- 1981-09-20 IL IL63890A patent/IL63890A0/xx unknown
- 1981-09-21 RO RO81105346A patent/RO82216A/ro unknown
- 1981-09-21 GR GR66108A patent/GR75046B/el unknown
- 1981-09-21 AT AT81304325T patent/ATE7657T1/de not_active IP Right Cessation
- 1981-09-21 FI FI812940A patent/FI812940L/fi not_active Application Discontinuation
- 1981-09-21 YU YU02271/81A patent/YU227181A/xx unknown
- 1981-09-21 PT PT73711A patent/PT73711B/pt unknown
- 1981-09-21 NO NO813208A patent/NO813208L/no unknown
- 1981-09-21 DE DE8181304325T patent/DE3163900D1/de not_active Expired
- 1981-09-21 AR AR286818A patent/AR229103A1/es active
- 1981-09-21 EP EP81304325A patent/EP0048615B1/en not_active Expired
- 1981-09-21 AU AU75516/81A patent/AU7551681A/en not_active Abandoned
- 1981-09-21 GB GB8128465A patent/GB2084573B/en not_active Expired
- 1981-09-21 ES ES505678A patent/ES8301225A1/es not_active Expired
- 1981-09-21 DK DK417981A patent/DK417981A/da not_active Application Discontinuation
- 1981-09-21 ZA ZA816549A patent/ZA816549B/xx unknown
- 1981-09-22 KR KR1019810003537A patent/KR830007597A/ko not_active Abandoned
- 1981-09-22 DD DD81233487A patent/DD201790A5/de unknown
- 1981-09-22 CS CS816978A patent/CS228536B2/cs unknown
- 1981-09-22 JP JP56150483A patent/JPS5785379A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR830007597A (ko) | 1983-11-04 |
| DD201790A5 (de) | 1983-08-10 |
| IL63890A0 (en) | 1981-12-31 |
| NO813208L (no) | 1982-03-23 |
| EP0048615A1 (en) | 1982-03-31 |
| PT73711B (en) | 1982-12-20 |
| ZA816549B (en) | 1983-04-27 |
| PT73711A (en) | 1981-10-01 |
| GB2084573B (en) | 1984-09-12 |
| AR229103A1 (es) | 1983-06-15 |
| FI812940A7 (fi) | 1982-03-23 |
| YU227181A (en) | 1983-10-31 |
| AU7551681A (en) | 1982-04-01 |
| GR75046B (enExample) | 1984-07-12 |
| ATE7657T1 (de) | 1984-06-15 |
| RO82216B (ro) | 1983-06-30 |
| US4346094A (en) | 1982-08-24 |
| ES505678A0 (es) | 1982-12-01 |
| JPS5785379A (en) | 1982-05-28 |
| PL233103A1 (enExample) | 1982-12-20 |
| EP0048615B1 (en) | 1984-05-30 |
| CS228536B2 (en) | 1984-05-14 |
| DK417981A (da) | 1982-03-23 |
| GB2084573A (en) | 1982-04-15 |
| DE3163900D1 (en) | 1984-07-05 |
| ES8301225A1 (es) | 1982-12-01 |
| FI812940L (fi) | 1982-03-23 |
| RO82216A (ro) | 1983-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL130497B1 (en) | Process for preparing novel derivatives of 3-aryl-5-isothiazole | |
| EP2482815B1 (en) | Antiinflammatory 2-oxothiazoles and 2-oxooxazoles | |
| EP0112623A2 (en) | 3-Aryl-5-pyrazole-carboxylic-acid derivatives, their preparation and pharmaceutical compositions | |
| HU226458B1 (en) | Benzothiophenecarboxamide derivatives, pharmaceutical compositions thereof and intermediates | |
| EP0342682A2 (en) | Hydroxamate derivatives of selected nonsteroidal anti-inflammatory acyl residues having cyclooxygenase and 5-lipoxygenase inhibition | |
| PT86811B (pt) | Processo para a preparacao de amidas de acidos gordos saturados inibidoras do acil-coenzima a: colesterol aciltransferase e de composicoes farmaceuticas que as contem | |
| KR101069276B1 (ko) | 대사 질환의 치료용 화합물 | |
| PT1369419E (pt) | Composto de n-fenilarilsulfonamida, fármaco contendo o composto como ingrediente activo, produtos intermédios para a produção do composto e processos para a produção do composto | |
| KR950004677B1 (ko) | 히드록시알킬시스테인 유도체 및 이를 함유하는 거담제 | |
| PT92180B (pt) | Processo para a preparacao de novas mevalonolactonas do tipo tienopiridina e de composicoes farmaceuticas que as contem | |
| JPS6261960A (ja) | 不可逆性ド−パミン−β−ヒドロキシラ−ゼ抑制剤 | |
| EP0592664B1 (en) | Derivatives of diphenylthiazole with antiinflammatory activity | |
| US4544752A (en) | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels | |
| Voorstad et al. | Comparison of the hypolipidemic activity of cyclic vs. acyclic imides | |
| US10894038B2 (en) | Indolizine derivatives, composition and methods of use | |
| JPS61218571A (ja) | 新規ラクタム誘導体及び新規チオラクタム誘導体並びに抗炎症剤 | |
| WO1989005295A1 (en) | Acyl derivatives of hydroxypyrimidines | |
| US4464379A (en) | Indol acetic acid derivatives and anti-inflamatory and related uses thereof | |
| PT831092E (pt) | Derivado de hidroquinona e a sua aplicacao farmaceutica | |
| US6048890A (en) | Phenylamidinothiophene derivatives and anti-inflammatory agent containing the same | |
| US20240116873A1 (en) | Quinoline mercaptoacetate sulfonamide derivative, intermediate, pharmaceutical derivative or formulation, and preparation method and use therefor | |
| US4883821A (en) | Agent for treating hyperuricemia | |
| JPH0665668B2 (ja) | フエニルピラジン誘導体および抗血栓剤 | |
| JP2741441B2 (ja) | Ｎ−アルキル−チアゾリジン誘導体 | |
| AU2023285760A1 (en) | Quinoline Mercaptoacetate Sulfonamide Derivative, Intermediate, Pharmaceutical Derivative Or Formulation, And Preparation Method And Use Therefor |